← SynDRA
SU3327
SynDRA canonical compound SYN1970702 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | MAPK8 |
| Mechanism of action | JNK inhibitor |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- SU-3327
- halicin
- 5-[(5-nitro-1,3-thiazol-2-yl)sulfanyl]-1,3,4-thiadiazol-2-amine
- Y4KQC5P9B2
- 2-Amino-5-[(5-nitro-2-thiazolyl)thio]-1,3,4-thiadiazole
- 5-(5-Nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine
- 5-[(5-Nitro-2-thiazolyl)thio]-1,3,4thiadiazol-2-amine
- 5-[(5-nitro-1,3-thiazol-2-yl)thio]-1,3,4-thiadiazol-2-amine
- 5-((5-Nitro-2-thiazolyl)thio)-1,3,4-thiadiazol-2-amine
- 5-[(5-Nitro-2-thiazolyl)thio]-1,3,4-thiadiazol-2-amine
- 1,3,4-Thiadiazol-2-amine, 5-((5-nitro-2-thiazolyl)thio)-
- 1,3,4-Thiadiazol-2-amine, 5-[(5-nitro-2-thiazolyl)thio]-
- UNII-Y4KQC5P9B2
- CHEMBL510038
- SCHEMBL8044196
- BDBM29315
- GTPL10703
- DTXSID70474254
- CHEBI:146227
- 2-amino-1,3,4-thiadiazole, 9
- HMS3414C07
- HMS3678C07
- BCP32078
- ZINC8716875
- MFCD01927019
- AKOS016368573
- compound 9 [PMID: 19271755]
- DB15624
- SU3327; SU-3327
- AS-77047
- BS175963
- HY-107597
- CS-0028934
- EC-000.2369
- JNK Inhibitor XIII - CAS 40045-50-9
- D88541
- A933919
- 5-((5-Nitrothiazol-2-yl)thio)-1,3,4-thiadiazol-2-amine
- 5-(5-Nitrothiazole-2-ylthio)-1,3,4-thiadiazole-2-amine
Look up SU3327 in the interactive SynDRA portal →